Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter

  • Yaxia Yuan
  • , Xiaoqin Huang
  • , Narasimha M. Midde
  • , Pamela M. Quizon
  • , Wei Lun Sun
  • , Jun Zhu
  • , Chang Guo Zhan

Producción científica: Article › revisión exhaustiva

44 Citas (Scopus)

Resumen

Nearly 70% of HIV-1-infected individuals suffer from HIV-associated neurocognitive disorders (HAND). HIV-1 transactivator of transcription (Tat) protein is known to synergize with abused drugs and exacerbate the progression of central nervous system (CNS) pathology. Cumulative evidence suggest that the HIV-1 Tat protein exerts the neurotoxicity through interaction with human dopamine transporter (hDAT) in the CNS. Through computational modeling and molecular dynamics (MD) simulations, we develop a three-dimensional (3D) structural model for HIV-1 Tat binding with hDAT. The model provides novel mechanistic insights concerning how HIV-1 Tat interacts with hDAT and inhibits dopamine uptake by hDAT. In particular, according to the computational modeling, Tat binds most favorably with the outward-open state of hDAT. Residues Y88, K92, and Y470 of hDAT are predicted to be key residues involved in the interaction between hDAT and Tat. The roles of these hDAT residues in the interaction with Tat are validated by experimental tests through site-directed mutagensis and dopamine uptake assays. The agreement between the computational and experimental data suggests that the computationally predicted hDAT-Tat binding mode and mechanistic insights are reasonable and provide a new starting point to design further pharmacological studies on the molecular mechanism of HIV-1-associated neurocognitive disorders.

Idioma originalEnglish
Páginas (desde-hasta)658-665
Número de páginas8
PublicaciónACS Chemical Neuroscience
Volumen6
N.º4
DOI
EstadoPublished - abr 15 2015

Nota bibliográfica

Publisher Copyright:
© 2015 American Chemical Society.

Financiación

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)R01 DA035552, R01 DA025100, R01 DA035714, R01 DA032910
National Stroke FoundationCHE-1111761
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseR01DA035552

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Physiology
    • Biochemistry
    • Cognitive Neuroscience
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter'. En conjunto forman una huella única.

    Citar esto